Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5080095
Max Phase: Preclinical
Molecular Formula: C45H57N7O7S
Molecular Weight: 840.06
Molecule Type: Unknown
Associated Items:
ID: ALA5080095
Max Phase: Preclinical
Molecular Formula: C45H57N7O7S
Molecular Weight: 840.06
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)COCCCCCCCC(=O)Nc2ccc(C(=O)Nc3ccccc3N)cc2)C(C)(C)C)cc1
Standard InChI: InChI=1S/C45H57N7O7S/c1-29-40(60-28-48-29)31-17-15-30(16-18-31)25-47-43(57)37-24-34(53)26-52(37)44(58)41(45(2,3)4)51-39(55)27-59-23-11-7-5-6-8-14-38(54)49-33-21-19-32(20-22-33)42(56)50-36-13-10-9-12-35(36)46/h9-10,12-13,15-22,28,34,37,41,53H,5-8,11,14,23-27,46H2,1-4H3,(H,47,57)(H,49,54)(H,50,56)(H,51,55)/t34-,37+,41-/m1/s1
Standard InChI Key: FXPXGKOQPGUBQC-RDGUTDORSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 840.06 | Molecular Weight (Monoisotopic): 839.4040 | AlogP: 6.06 | #Rotatable Bonds: 19 |
Polar Surface Area: 205.08 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 14 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 4 |
CX Acidic pKa: 12.29 | CX Basic pKa: 3.24 | CX LogP: 3.97 | CX LogD: 3.97 |
Aromatic Rings: 4 | Heavy Atoms: 60 | QED Weighted: 0.05 | Np Likeness Score: -0.81 |
1. Smalley JP, Baker IM, Pytel WA, Lin LY, Bowman KJ, Schwabe JWR, Cowley SM, Hodgkinson JT.. (2022) Optimization of Class I Histone Deacetylase PROTACs Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and Cell Arrest in Cancer Cells., 65 (7.0): [PMID:35293758] [10.1021/acs.jmedchem.1c02179] |
Source(1):